These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 946766)
1. Letter: Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis. Nelson D Arch Neurol; 1976 May; 33(5):373. PubMed ID: 946766 [No Abstract] [Full Text] [Related]
2. Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study. Heun R; Sliwka U; Rüttinger H; Schimrigk K J Neurol; 1992 Jan; 239(1):31-5. PubMed ID: 1541966 [TBL] [Abstract][Full Text] [Related]
3. Spinal injections of corticosteroids. Med J Aust; 1982 Jan; 1(1):9-12. PubMed ID: 6895926 [No Abstract] [Full Text] [Related]
4. Complications from intrathecal steroid therapy in patients wsith multiple sclerosis. Nelson DA; Vates TS; Thomas RB Acta Neurol Scand; 1973; 49(2):176-88. PubMed ID: 4740461 [No Abstract] [Full Text] [Related]
5. Spinal Syrinx Due to Lipiodol-Induced Arachnoiditis. Paquet J; Cordier F; Vandersteene J World Neurosurg; 2021 May; 149():64-66. PubMed ID: 33601077 [TBL] [Abstract][Full Text] [Related]
6. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces. Abel R; Nelson DA; Bernat JL Del Med J; 1977 Jun; 49(6):331-43. PubMed ID: 577483 [No Abstract] [Full Text] [Related]
7. [Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids]. Voltz R; Hohlfeld R Nervenarzt; 1992 Dec; 63(12):773-5. PubMed ID: 1494395 [No Abstract] [Full Text] [Related]
8. [Arachnoiditis of atypical appearance (author's transl)]. Barny F; Bernier J; Menu Y; Gaston A; Barcat E J Radiol; 1981; 62(6-7):397-9. PubMed ID: 7288740 [No Abstract] [Full Text] [Related]
9. Spinal injection of corticosteroids. Gibb D Med J Aust; 1981 Sep; 2(6):302-3. PubMed ID: 6895402 [No Abstract] [Full Text] [Related]
10. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al]. Hohlfeld R; Engelhardt D Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771 [No Abstract] [Full Text] [Related]
11. [Cortisol suppression in corticoid therapy. Comments on the contribution by R. Voltz and R. Hohlfeld. Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids]. Haupts M; Schlüter T; Gehlen W Nervenarzt; 1993 Jun; 64(6):413. PubMed ID: 8332236 [No Abstract] [Full Text] [Related]
12. [Intrathecal corticosteroids in multiple sclerosis. Review of the literature and personal cases]. Giunta A; Palchetti R; Tortoli V Rass Neurol Veg; 1965 Apr; 19(1):123-42. PubMed ID: 5325554 [No Abstract] [Full Text] [Related]
13. [Questioning the responsibility of arachno-epiduritis in determining refractory lumbosciatica, following surgical intervention, saccoradiculography or intra-spinal injections of corticoids]. Desproges-Gotteron R; Treves R Bull Acad Natl Med; 1984; 168(3-4):357-61. PubMed ID: 6383559 [No Abstract] [Full Text] [Related]
15. Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin. Kaufman M Mult Scler; 1997 Aug; 3(4):248-9. PubMed ID: 9372508 [TBL] [Abstract][Full Text] [Related]